Article
AstraZeneca's Tagrisso, chemo combination shows promise in lung cancer trial
Rating:
0.0
Views:
113
Likes:
1
Library:
1
The combination of AstraZeneca's cancer drug, Tagrisso, with chemotherapy to treat patients with a type of lung cancer showed positive results in a late-stage trial, the company said on Wednesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value